Virus-directed enzyme prodrug therapy and the assessment of the cytotoxic impact of some benzimidazole derivatives

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives

(2016) Katarzyna Błaszczak-Świątkiewicz et al.   TUMOR BIOLOGY

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

(2015) Mitesh J. Borad et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene-Directed Enzyme Prodrug Therapy

(2014) Jin Zhang et al.   AAPS Journal

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

(2014) Sant P. Chawla et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting hypoxia in the treatment of small cell lung cancer

(2014) J.L. Bryant et al.   LUNG CANCER

Biological Evaluation of the Activity of Some Benzimidazole-4,7-dione Derivatives

(2014) Katarzyna Błaszczak-Świątkiewicz et al.   MOLECULES

Prodrugs: A challenge for the drug development

(2014) Jolanta B. Zawilska et al.   Pharmacological Reports

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy

(2014) Sven Hagen et al.   Scientific Reports

History of gene therapy

(2013) Thomas Wirth et al.   GENE

Tirapazamine Sensitizes Hepatocellular Carcinoma Cells to Topoisomerase I Inhibitors via Cooperative Modulation of Hypoxia-Inducible Factor-1 

(2013) T.-Y. Cai et al.   MOLECULAR CANCER THERAPEUTICS

Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology

(2012) Paul Zarogouldis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES